Fundz
Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →

Auron Therapeutics announced it raised $7.12 Million in an initial filing from an offering of $12 Million

PRIVATEAug 13, 2026•about 2 hours ago

Amount Raised

$7.12 Million

Round Type

Venture - Series Unknown

WellesleyBiotechnology

Company Information

Company

Auron Therapeutics

Location

7 NORWICH ROAD

Wellesley, Massachusetts, United States

About

Auron Therapeutics is a platform-based, product-driven biotechnology company focused on developing therapies that target cellular plasticity for solid tumor cancers and hematological malignancies. Auron has built a proprietary AI-powered platform that integrates large, multi-omic datasets to rapidly compare tumor tissue to normal tissues and enable a systems-biology understanding of the pathways that are associated with tumor plasticity, dysregulated differentiation, and treatment resistance.

Don't miss Auron Therapeutics's next move

Get an email the moment Auron Therapeutics raises, hires an exec, or expands — usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Suggested for you
2 contacts
Verified contactsDavid M., Chief Scientific Officer hidden hidden
Predictive Intelligence
Strategic

ML-powered predictions for Auron Therapeutics's next move

Learn about Strategic plan

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.